Sheel Biotech shares list at 44% premium over IPO price on NSE SME platform

Sheel Biotech, a diversified agri-biotech company specializing in tissue culture, organic farming, and greenhouse solutions, made a blockbuster debut on the NSE SME platform on Wednesday. Sheel Biotech share listed at Rs 91 apiece on the BSE SME, marking a 44% premium over the IPO price of Rs 63

Ahead of the listing, the grey market premium on Sheel Biotech shares hovered at 16% hinting at decent gains. The Rs 34 crore IPO, which closed on October 3, received solid investor interest across categories.

The issue was subscribed 15.97 times overall, led by strong institutional and non-institutional demand. The QIB category was subscribed to 19.73 times, while HNIs bid 25.92 times and retail investors 9.56 times. The anchor book also saw healthy participation, raising Rs 9.6 crore on September 29.


Also read: LG Electronics and Tata Capital grab attention in a crowded IPO market. Which is a better investment for you?

Sheel Biotech has over three decades of experience in biotechnology, horticulture, and sustainable agriculture. Incorporated in 1991, the company produces high-quality, disease-free planting materials through tissue culture and hydroponics.

It also designs and implements greenhouses, integrated packhouses, and turnkey horticultural projects using modern technologies like climate control and fertigation. Additionally, it assists farmers in organic certification and operates Farmer Producer Organizations (FPOs) to provide training and market linkages.

Financially, Sheel Biotech has shown steady growth. Revenue rose 11% year-on-year to Rs 102.27 crore in FY25, while profit after tax inched up to Rs 10.64 crore from Rs 10.47 crore a year earlier.

The proceeds will be used for capital expenditure and working capital needs, helping Sheel expand capacity and strengthen operations.

If overall market sentiment holds firm, Sheel Biotech could see a stable debut in the Rs 72–75 range, delivering modest gains while setting a steady foundation for future growth.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)